A new study has found that the cholesterol-lowering drug atorvastatin can prevent heart disease and help individuals with type 2 diabetes live longer even if they have normal cholesterol levels. The study involved >2800 patients with diabetes who were split into 2 groups. One group was given atorvastatin and the other given placebo pills.
During a 4-year period, the patients who took the statin were 27% less likely to die and 37% less likely to have a heart attack or stroke. The researchers concluded that the drug should be given to patients with type 2 diabetes even if they have normal cholesterol levels. Yet, one expert argued that it was too early to recommend that all type 2 diabetics take cholesterol-lowering drugs. (The findings were published in the Lancet, August 21, 2004.)
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.
Clinical features with downloadable PDFs